Cohort plc (FRA:C7K)

Germany flag Germany · Delayed Price · Currency is EUR
13.50
-0.10 (-0.74%)
Last updated: Feb 20, 2026, 8:04 AM CET
Market Cap635.25M +8.2%
Revenue (ttm)319.55M +23.9%
Net Income20.79M -5.9%
EPS0.45 -17.0%
Shares Outn/a
PE Ratio30.55
Forward PE18.89
Dividend0.19 (1.44%)
Ex-Dividend DateJan 8, 2026
Volume1,332
Average Volume175
Open13.50
Previous Close13.60
Day's Range13.50 - 13.50
52-Week Range10.00 - 20.40
Betan/a
RSI55.00
Earnings DateMar 13, 2026

About Cohort

Cohort plc provides various products and services in defense, security, and related markets in the United Kingdom, Germany, Portugal, Australia, North and South America, Asia Pacific, Africa, and other European countries. It operates through Communications and Intelligence; and Sensors and Effectors segments. The company offers chess dynamic, a surveillance and fire control which provides bespoke solutions for land and maritime domains; and combat systems. It also provides integrated command, control, and communications systems for warships and... [Read more]

Industry Computer Programming, Data Processing, And Other Computer Related Services
Founded 2006
Employees 1,647
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C7K
Full Company Profile

Financial Performance

In fiscal year 2025, Cohort's revenue was 270.04 million, an increase of 33.33% compared to the previous year's 202.53 million. Earnings were 19.25 million, an increase of 25.68%.

Financial numbers in GBP Financial Statements

News

Cohort PLC At Investor Presentation Transcript

Cohort PLC At Investor Presentation Transcript

5 weeks ago - GuruFocus

Cohort PLC Investor Presentation Transcript

Cohort PLC Investor Presentation Transcript

5 weeks ago - GuruFocus

Cohort PLC (FRA:C7K) (H1 2026) Earnings Call Highlights: Record Revenue Amidst Profitability ...

Cohort PLC (FRA:C7K) (H1 2026) Earnings Call Highlights: Record Revenue Amidst Profitability Challenges

2 months ago - GuruFocus

Half Year 2026 Cohort PLC Earnings Presentation Transcript

Half Year 2026 Cohort PLC Earnings Presentation Transcript

2 months ago - GuruFocus

Half Year 2026 Cohort PLC Earnings Call Transcript

Half Year 2026 Cohort PLC Earnings Call Transcript

2 months ago - GuruFocus

Protara Reports Updated Interim Phase 2 Data Of TARA-002 In Non-muscle Invasive Bladder Cancer

(RTTNews) - Protara Therapeutics, Inc. (TARA) has reported new interim results from Cohort A of its ongoing Phase 2 ADVANCED-2 trial of TARA-002 in BCG- naïve patients with high-grade non-muscle invas...

2 months ago - Nasdaq

Protara To Present New Interim Phase 2 Data Of TARA-002 In Bladder Cancer Next Month

(RTTNews) - Protara Therapeutics Inc. (TARA) is scheduled to present new interim data from Cohort A of its ongoing Phase 2 trial assessing investigational cell-based therapy, TARA-002, in patients wit...

3 months ago - Nasdaq